SCHEMBL30120162

SCHEMBL30120162

Oc1ccc2ncc(Cl)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
ESR2 Q92731 4/20 0.46
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
TTR P02766 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
ENPP2 Q13822 1/20 0.41
MAPT P10636 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPK10 P53779 1/20 0.39
ATM Q13315 1/20 0.39
ESR1 P03372 3/20 0.39
ESRRB O95718 1/20 0.39
ESRRA P11474 1/20 0.39
BCHE P06276 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24753435 1.00 ALDH1A1 (0.52) ALDH1A1ESR2PDGFRBPDGFRAMEN1
SCHEMBL1664655 0.92 ALDH1A1 (0.52) ALDH1A1ESR2PDGFRBPDGFRAMEN1
SCHEMBL1441691 0.85 ESR2 (0.49) ALDH1A1ESR2PDGFRBPDGFRAMEN1
SCHEMBL629503 0.79 ALDH1A1 (0.55) ALDH1A1PDGFRBPDGFRAMEN1KMT2A
SCHEMBL30775025 0.79 ALDH1A1 (0.55) ALDH1A1PDGFRBPDGFRAMEN1KMT2A
SCHEMBL621353 0.76 ALDH1A1 (0.52) ALDH1A1PDGFRBPDGFRAMEN1KMT2A
SCHEMBL361089 0.76 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL9912661 0.76 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ACASP1KDM4E
SCHEMBL12928106 0.76 ALDH1A1 (0.52) ALDH1A1HPGDNPC1
SCHEMBL2629408 0.76 ALDH1A1 (0.46) ALDH1A1ESR2PDGFRBPDGFRAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096858-A1 COMPOUNDS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed